Evidence map›Paper›PMID 36151743›Full record

ArticleJournal of dual diagnosis

Changes in Alcohol Consumption following Direct-Acting Antiviral Treatment for Hepatitis C in VA Patients with Comorbid Alcohol Use Disorder and PTSD.

Jessica E Hoyt, Nikhil Teja, Tammy Jiang, Luke Rozema, Jiang Gui, Bradley V Watts, Brian Shiner, Jaimie L Gradus

Open access · greenAbstract read
In one paragraph

Article in Journal of dual diagnosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jessica E HoytWhite River Junction Veterans Affairs Medical Center, White River Junction, Vermont, USA.
Nikhil TejaWhite River Junction Veterans Affairs Medical Center, White River Junction, Vermont, USA.
Tammy JiangBoston University School of Public Health, Boston, Massachusetts, USA.
Luke RozemaWhite River Junction Veterans Affairs Medical Center, White River Junction, Vermont, USA.
Jiang GuiWhite River Junction Veterans Affairs Medical Center, White River Junction, Vermont, USA.
Bradley V WattsWhite River Junction Veterans Affairs Medical Center, White River Junction, Vermont, USA.
Brian ShinerWhite River Junction Veterans Affairs Medical Center, White River Junction, Vermont, USA.
Jaimie L GradusBoston University School of Public Health, Boston, Massachusetts, USA.
White River Junction VA Medical Center · USBoston University · USDartmouth College · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
Identification of Novel Agents to Treat PTSD using Clinical DataR01MH121397 · NIMH · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GRADUS, JAIMIE L., SHINER, BRIAN · 2020 to 2023
$2.3M
NCI NIH HHS P30 CA023108NIMH NIH HHS R01 MH121397
6 · The paper itself

Abstract

objectiveTo investigate whether direct-acting antivirals (DAA) for hepatitis C viral infection (HCV): glecaprevir/pibrentasvir (GLE/PIB), ledipasvir/sofosbuvir (LDV/SOF), and sofosbuvir/velpatasvir (SOF/VEL) are associated with reduced alcohol consumption among veterans with alcohol use disorder (AUD) and co-occurring post-traumatic stress disorder (PTSD).

methodsWe measured change in Alcohol Use Disorder Identification Test-Consumption Module (AUDIT-C) scores in a retrospective cohort of veterans with PTSD and AUD receiving DAAs for HCV.

resultsOne thousand two hundred and eleven patients were included (GLE/PIB

conclusionsDAA treatment for HCV was associated with a substantial reduction in alcohol use in patients with AUD and co-occurring PTSD. Further exploration of the role of DAAs in AUD treatment is warranted.

Indexed as

AlcoholismHepatitis CHepatitis C, ChronicStress Disorders, Post-TraumaticAlcohol DrinkingAntiviral AgentsBenzimidazolesFluorenesHepacivirusHumansRetrospective StudiesSofosbuvirTreatment OutcomeAntiviral AgentsBenzimidazolesFluorenesledipasvir, sofosbuvir drug combinationSofosbuviralcohol use disorderdirect-acting antiviralHepatitis Cpost-traumatic stress disorder

Identifiers

PMID36151743
PMCPMC9719291
OpenAlexW4296919191

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.